| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA692302 | F | NPY Y1-antagonistic activity in HEL cells by measuring the inhibition of porcine NPY (10 nM) stimulated increase in the intracellular [Ca2+] concentration in a FURA-assay;Inactive, less than 20% inhibition at 100 mM | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
| 2. | ALA691332 | F | Tested for Antiherpetic activity against VZV from Kawaguchi strain in HEL cell lines. | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 3. | ALA691333 | F | Tested for Antiherpetic activity against VZV from clinical isolates of HEL cell lines.(average of 11 isolates) | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
| 4. | ALA691334 | F | Tested for inhibitory activity against Varicella zoster virus(VZV) by plaque reduction assay using HEL cells | Homo sapiens | 14 | cell-based format | Scientific Literature | ||
| 5. | ALA691335 | F | The compound was tested for Anti-VZV activity against 07/1 strain TK- in HEL cells | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 6. | ALA691336 | F | The compound was tested for Anti-VZV activity against YS strain TK+ in HEL cells | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 7. | ALA691512 | F | The compound was tested for Anti-VZV activity against YS/R strain TK- in HEL cells | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 8. | ALA691513 | F | The compound was tested for anti CMV (Cytomegalovirus- virus) activity against AD-169 strain in HEL cells;d ='not determined' | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 9. | ALA691514 | F | The compound was tested for anti CMV (Cytomegalovirus- virus) activity against Davis strain in HEL cells;d ='not determined' | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 10. | ALA691515 | F | The compound was tested for antiviral activity by measuring the concentration required to reduce plaque formation against Varicella zoster TK+OKA strain | Homo sapiens | 11 | cell-based format | Scientific Literature | ||
| 11. | ALA691516 | F | The compound was tested for antiviral activity by measuring the concentration required to reduce plaque formation against Varicella zoster TK+OKA strain; Not determined | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 12. | ALA691517 | F | The compound was tested for antiviral activity by measuring the concentration required to reduce plaque formation against Varicella zoster TK+YS strain | Homo sapiens | 11 | cell-based format | Scientific Literature | ||
| 13. | ALA691518 | F | The compound was tested for antiviral activity by measuring the concentration required to reduce plaque formation against Varicella zoster TK+YS strain; Not determined | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 14. | ALA691519 | F | The compound was tested for antiviral activity by measuring the concentration required to reduce plaque formation against Varicella zoster TK-(deficient) 07/1 strain | Homo sapiens | 11 | cell-based format | Scientific Literature | ||
| 15. | ALA691520 | F | The compound was tested for antiviral activity by measuring the concentration required to reduce plaque formation against Varicella zoster TK-(deficient) 07/1 strain; Not determined | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 16. | ALA691521 | F | The compound was tested for antiviral activity by measuring the concentration required to reduce plaque formation against Varicella zoster TK-(deficient) YS/R strain | Homo sapiens | 11 | cell-based format | Scientific Literature | ||
| 17. | ALA691522 | F | The compound was tested for antiviral activity by measuring the concentration required to reduce plaque formation against Varicella zoster TK-(deficient) YS/R strain; Not determined | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 18. | ALA879475 | F | The compound was tested for antiviral activity by measuring the concentration required to reduce plaque formation against cytomegalo virus AD-169 strain | Homo sapiens | 11 | cell-based format | Scientific Literature | ||
| 19. | ALA691523 | F | The compound was tested for antiviral activity by measuring the concentration required to reduce plaque formation against cytomegalo virus AD-169 strain; Not determined | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 20. | ALA691524 | F | The compound was tested for antiviral activity by measuring the concentration required to reduce plaque formation against cytomegalo virus Davis strain | Homo sapiens | 11 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!